---
category: listing
circular_id: 17a0b2d6e0ff66ca
date: '2025-07-30'
description: BSE lists 26,69,951 new equity shares of Astec Lifesciences Limited issued
  on rights basis, effective July 31, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={A80E6040-2446-491C-8A6D-557DB7564F89}&noticeno=20250730-57&dt=07/30/2025&icount=57&totcount=59&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Rights issue listing affects existing shareholders and increases share
  capital but is routine corporate action
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250730-57&attachedId=
processing:
  attempts: 1
  content_hash: 828b6ad6aa501598
  processed_at: '2025-07-30T18:32:18.333726'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-07-30T16:05:15+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={A80E6040-2446-491C-8A6D-557DB7564F89}&noticeno=20250730-57&dt=07/30/2025&icount=57&totcount=59&flag=0
severity: low
source: bse
stocks:
- ASTEC
tags:
- listing
- rights-issue
- equity-shares
- astec-lifesciences
title: Listing of new Securities of Astec Lifesciences Limited
---

## Summary

BSE has approved the listing of 26,69,951 new equity shares of Astec Lifesciences Limited (Scrip Code: 533138) issued through a rights offering. The shares will commence trading on July 31, 2025.

## Key Points

- 26,69,951 equity shares of Rs. 10/- each issued at premium of Rs. 880/-
- Rights basis issuance with allotment date of July 29, 2025
- ISIN: INE563J01010
- Distribution numbers: 19611711 to 22281661
- Shares rank pari-passu with existing equity shares

## Regulatory Changes

No regulatory changes introduced.

## Compliance Requirements

Trading members are informed of the new securities availability for trading.

## Important Dates

- Allotment Date: July 29, 2025
- Trading Commencement: July 31, 2025

## Impact Assessment

The rights issue increases Astec Lifesciences' share capital and provides existing shareholders with additional equity participation. The premium pricing at Rs. 880/- suggests strong market confidence in the company's prospects.